Evolving With Our Customers - A $100 Million Expansion

Innovative therapeutics and drug delivery systems capable of delivering more effective, patient-centric treatment plans are shifting the manufacturing needs of many pharmaceutical and biotech companies. To meet this shifting demand, manufacturing partners must also evolve to meet customer needs and deliver safe, high-quality products to patient populations.

Baxter BioPharma Solutions’ approximately $100 million expansion of its sterile fill/finish manufacturing facility in Halle/Westfalen, Germany adds state-of-the-art equipment for the filling of vials and pre-filled syringes to help meet the growing demand for biologics and self-administered doses. Both manufacturing lines will be set up to offer a wide range of flexibility to meet the customers' demands from both a capability and capacity standpoint. Discover the potential for innovative solutions in this recent expansion.